These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6277130)

  • 1. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
    Woodland E; Tunny TJ; Hamlet SM; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
    Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
    Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
    Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
    Stowasser M; Gordon RD; Klemm SA; Tunny TJ
    J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
    Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
    New MI; Peterson RE; Saenger P; Levine LS
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
    Fallo F; Sonino N; Boscaro M; Armanini D; Mantero F; Dörr HG; Knorr D; Kuhnle U
    Klin Wochenschr; 1987 May; 65(10):437-44. PubMed ID: 3037179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
    Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
    Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
    Sonino N; Levine LS; New MI
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):87-94. PubMed ID: 7025545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
    O'Mahony S; Burns A; Murnaghan DJ
    J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
    Gill JR; Bartter FC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
    Connell JM; Jardine A; Fraser R
    Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
    [No Abstract]   [Full Text] [Related]  

  • 18. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperaldosteronism suppressed after glucocorticoid administration].
    Brzezińska A; Słowińska-Srzednicka J; Wieteska-Klimczak A; Wyszyńska T; Januszewicz P
    Endokrynol Pol; 1992; 43(3):330-5. PubMed ID: 1345573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.